BIOMAT Database Logo BIOMAT Database Logo

Screening for cystic fibrosis: use of delta F508 mutation. 1990

F G Bowling, and J J McGill, and R W Shepherd, and D M Danks

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
January 1998, Journal of medical screening,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Prenatal screening for delta F508 mutation in population not selected for cystic fibrosis.
November 1990, Lancet (London, England),
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
A pooling strategy for heterozygote screening of the delta F508 cystic fibrosis mutation.
January 1991, Human genetics,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
[Detection of delta F508 mutation in cystic fibrosis].
September 1992, Orvosi hetilap,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Age of the delta F508 cystic fibrosis mutation.
November 1994, Nature genetics,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Young's syndrome and cystic fibrosis mutation delta F508.
July 1993, Lancet (London, England),
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Rapid screening for delta F508 deletion in cystic fibrosis.
December 1989, Lancet (London, England),
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
A mouse model for the cystic fibrosis delta F508 mutation.
September 1995, The EMBO journal,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
Cystic fibrosis delta F508 mutation in a French population.
January 1991, Advances in experimental medicine and biology,
F G Bowling, and J J McGill, and R W Shepherd, and D M Danks
The cystic fibrosis delta F508 gene mutation and cancer.
January 1997, Human mutation,
Copied contents to your clipboard!